Business Wire

HIGHWIRE

25.3.2020 09:02:06 CET | Business Wire | Press release

Share
HighWire Reinforces Commitment to Supporting Dissemination of Knowledge During COVID-19 Epidemic

Scholarly publishing technology provider, HighWire, has announced its ongoing commitment to enabling access to critical information and supporting the dissemination of knowledge during the COVID-19 pandemic.

The organization, which supports and hosts key information providers such as WHO, BMJ, Cochrane and AAAS, has a robust business continuity plan in place which has been communicated to all clients. HighWire is proud of the work its partners and clients are carrying out at this unprecedented time, underpinned by HighWire’s technology platforms.

The BMJ and AAAS’ Science Magazine , both of which host journals with HighWire, have made all articles and coverage of the coronavirus freely available, empowering researchers in this time of global need. HighWire continues to achieve uptime targets of 99.8% to ensure that these prominent and vital information sources remain accessible.

The creation of the Campus Activated Subscriber Access (CASA) initiative, co-developed by HighWire alongside Google Scholar, is enabling seamless off-campus and mobile access to subscribed scholarly content, helping students and researchers stay up to date wherever they are.

The launch last year of medRxiv - in conjunction with Cold Spring Harbor, BMJ and Yale - is also playing a critical role in rapidly disseminating medical information in a fluid and evolving landscape.

John Inglis, co-founder of bioRxiv and medRxiv, said, "The pandemic is an international tragedy and there is an urgent need for sharing new information on all aspects of COVID-19 quickly, freely, and responsibly. To help with this task, physicians and scientists worldwide have turned to medRxiv and bioRxiv in growing numbers to distribute their own recent research and find out what colleagues elsewhere are learning."

“We are seeing elevated traffic across the board to our clients in the STM publishing space as the scientific community responds to this rapidly evolving situation, and are proud to say that our platforms continue to perform well,” said Tim Bacci, CEO at HighWire. “We are immensely grateful to our partners, clients, and members of the whole of the research ecosystem for their diligence, dedication and passion during this emergency, and we will continue to support them in every way possible.”

###

About HighWire

HighWire is a global provider of digital publishing solutions and platform expertise across all aspects of the publishing life cycle, including content management and hosting, e-commerce, analytics, access and identity management, manuscript submission and tracking.

Born out of Stanford University and now celebrating its 25th year, HighWire is backed by Stanford and private equity firm Accel-KKR, recently listed as the top founder-friendly investors for entrepreneurial partnership. This combination of deep digital understanding, academic expertise and strong financial backing makes HighWire the technology partner of choice for world-leading commercial and academic publishers.

For more information, please visit highwirepress.com and follow us on Twitter , LinkedIn and Facebook .

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Okomera Strengthens Its Leadership Team With the Appointment of Marion Ghibaudo as Chief Technology Officer16.9.2026 08:00:00 CEST | Press release

An expert in scaling medical innovations, Marion Ghibaudo joins Okomera as the company advances toward industrial deployment. Okomera, a TechBio company pioneering next-generation cancer care through the development of a proprietary technology platform combining tumor mini-avatars, microfluidics, and AI-powered imaging, today announced the appointment of Marion Ghibaudo as Chief Technology Officer. She will spearhead the company’s technology and innovation strategy and lead the industrial deployment of its integrated hardware, software, and biological platform. Marion Ghibaudo will join Okomera’s Executive Committee and report to CEO Silvère Lucquin. In parallel, Raphaël Tomasi, Okomera’s co-founder and former CTO, transitions to the role of VP Platform, ensuring continuity in the development of the company’s technology platform. Marion’s appointment comes at a key stage in Okomera’s growth as the company advances toward pilot studies, industrial scale-up, and commercialization. Okomer

Galderma’s Restylane® Volyme™ Demonstrates High Effectiveness, Satisfaction and a Robust Safety Profile in Chinese Patients With Temple Hollowing16.9.2026 07:00:00 CEST | Press release

Positive topline results showed that Restylane Volyme (known as Restylane Contour in the U.S.) was highly effective in the correction of moderate-to-severe temple hollowing, with high responder rates maintained through Month 121 Restylane Volyme was well tolerated, with no incidences of granulomas. Patient and investigator satisfaction were also high1 These data support Galderma’s aim to expand the availability of the Restylane portfolio in China – a market undergoing significant expansion, and further strengthen Restylane’s vast clinical evidence base2,3 Galderma (SIX: GALD) today announced positive topline results from a study of Restylane Volyme for the correction of moderate-to-severe temple hollowing in 162 patients in China.1 The study met its primary endpoint, demonstrating the effectiveness and safety of Restylane Volyme versus a no-treatment control, while also achieving high patient and investigator satisfaction.1 These data further reinforce Galderma's ambition to expand its

Nippon Electric Glass’s IR Transmitting Glass “FI-02” Adopted for Heimann Sensor Lens Unit, Enabling a 120° × 68° Field of View16.9.2026 03:00:00 CEST | Press release

Nippon Electric Glass Co., Ltd. (NEG) (TOKYO: 5214), a global leader in specialty glass headquartered in Otsu, Japan, announced that its IR Transmitting Glass (chalcogenide glass) “FI-02” has been adopted for Heimann Sensor GmbH’s wide-angle lens unit for thermal cameras. The lens unit achieves a 120° × 68° field of view, surpassing the previous product’s maximum of 92° × 59°. The adoption marks a significant milestone for FI-02 and showcases how advanced specialty glass can meet the demanding optical and manufacturing requirements of the expanding infrared sensing market. Thermal cameras detect infrared radiation emitted by people or objects and convert it into thermal images. Infrared sensors can detect the locations of people and temperature distributions. They are expected to be used for people detection and monitoring, where privacy considerations are important, and for air-conditioning control, while their use is expanding in healthcare, equipment monitoring, and security. Advanc

Workiva Advances Regulatory Work with AI Innovation15.9.2026 17:00:00 CEST | Press release

Agent Studio anchors AI capabilities unveiled at Amplify 2026 Workiva Inc. (NYSE: WK), a leading, audit-ready platform for trust, transparency, and accountability, unveiled dozens of new product and platform innovations at Amplify 2026, the company’s annual conference attended by thousands of finance, accounting, sustainability, risk, and compliance leaders. Workiva Debuts Agent Studio Workiva introduced Agent Studio, a landmark platform capability that empowers users to quickly build, customize, and deploy AI agents in Workiva's trusted platform. By combining AI reasoning with Workiva's native platform capabilities, enterprise knowledge, and governed workflows, Agent Studio enables users to automate sophisticated manual business processes without writing any code. Organizations can enrich agents with company-specific knowledge and context, tailor them to their own processes, and schedule automations to execute recurring work. “With Agent Studio, we're putting the power to build in the

Study: Heatwaves Increase Cough Urge, Which Salt Aerosols Reduce15.9.2026 15:15:00 CEST | Press release

New Study Indicates Non-Pharmacological Aerosol May Provide Therapeutic Relief for Respiratory Conditions Provoked by the Atmospheric Aridity Inherent to Heatwaves SC Therapeutics, with University North Carolina, Imperial College London, and Boston University, announced publication on Tuesday in Nature Scientific Reports of results from a multi-institutional study indicating that the aridity inherent in heatwaves increases cough hypersensitivity in human airways by collapsing mucus onto cilia in a manner common to chronic respiratory diseases, such as cystic fibrosis, and asthma. The researchers find that alkaline aerosols of magnesium salts reverse mucosal collapse for several hours, and reduce cough hypersensitivity as reflected in placebo-adjusted suppression of daily cough bout rate (59%, p=0.03) and persistence of suppression post treatment for 1 to 3 weeks in a randomized, double-blind, placebo-controlled study of 10 refractory chronic cough patients. “Paris recorded 5,764 excess

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye